H.J. Res. 46 (119th)Bill Overview

Disapprove EPA Decabromodiphenyl Ether and Phenol, Isopropylated Phosphate (3:1…

CRA DisapprovalEnvironmental Protection|Environmental Protection
Cosponsors
Support
Republican
Introduced
Feb 12, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
CRA DisapprovalWhat this resolution actually does

This resolution uses the Congressional Review Act to try to nullify a federal agency rule by passing a joint resolution of disapproval. If enacted, the rule would be legally void and the agency would be restricted from issuing a substantially similar rule without new law. The joint resolution must be passed by both chambers of Congress and presented to the President for signature or veto.

Rule targeted

Decabromodiphenyl Ether and Phenol, Isopropylated Phosphate (3:1); Revision to the Regulation of Persistent, Bioaccumulative, and Toxic Chemicals Under the Toxic Substances Control Act (TSCA) (89 Fed. Reg. 91486, Nov. 19, 2024).

Issuing agency

Environmental Protection Agency (EPA)

Passage rules

Under the Congressional Review Act, disapproval resolutions get expedited consideration in the Senate and are not subject to a filibuster, so they can pass by a simple majority; after passage in both chambers the resolution is sent to the President for signature or veto.

This joint resolution seeks congressional disapproval, under the Congressional Review Act, of an Environmental Protection Agency rule titled “Decabromodiphenyl Ether and Phenol, Isopropylated Phosphate (3:1); Revision to the Regulation of Persistent, Bioaccumulative, and Toxic Chemicals Under the Toxic Substances Control Act (TSCA).” If enacted, the resolution would nullify the EPA rule (89 Fed.

Reg. 91486, Nov. 19, 2024) and prevent the agency from issuing the same rule in substantially identical form.

The measure was referred to the House Committee on Energy and Commerce.

Passage30/100

Simple statutory mechanism but politically charged regulatory rollback; must clear both chambers and be signed, increasing hurdles.

CredibilityAligned

Relative to its intended legislative type, this bill is a narrowly focused Congressional Review Act disapproval that clearly identifies the target rule and provides the minimal, specific operative language needed to render the rule without force or effect.

Contention78/100

Progressives emphasize health and environmental protection losses.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
ManufacturersLikely burdened

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • ManufacturersPrevents compliance costs for manufacturers and importers of products containing DecaBDE and PIP(3:1).
  • Potential benefitPreserves jobs in affected manufacturing and downstream sectors by avoiding new regulatory compliance.
  • Potential benefitReduces regulatory burden and paperwork for companies handling these chemicals.
Likely burdened
  • Potential burdenContinues potential environmental and human exposure to persistent, bioaccumulative toxic chemicals.
  • Potential burdenShifts potential cleanup and public health costs to governments and affected communities.
  • Potential burdenLimits EPA's ability to regulate chemical risks under TSCA and address emerging hazards.
03 · Why people split

Why the argument around this bill splits.

Progressives emphasize health and environmental protection losses.
Progressive10%

Likely opposed: views disapproval as a rollback of chemical safety protections and EPA authority.

Sees the resolution as harmful to public health, environmental justice, and communities exposed to persistent toxic chemicals.

Likely resistant
Centrist50%

Mixed view: wants to balance chemical safety with economic impacts and rulemaking quality.

Would evaluate scientific basis, cost-benefit analysis, and administrative procedure before taking a firm position.

Split reaction
Conservative90%

Likely supportive: views disapproval as curbing EPA overreach and preventing costly, burdensome federal regulation.

Emphasizes economic and federalism arguments and skepticism of aggressive administrative rulemaking.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood30/100

Simple statutory mechanism but politically charged regulatory rollback; must clear both chambers and be signed, increasing hurdles.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Which congressional majority supports deregulatory CRA use
  • Level of industry or environmental stakeholder mobilization
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressives emphasize health and environmental protection losses.

Simple statutory mechanism but politically charged regulatory rollback; must clear both chambers and be signed, increasing hurdles.

Unlocked analysis

Relative to its intended legislative type, this bill is a narrowly focused Congressional Review Act disapproval that clearly identifies the target rule and provides the minimal, specific operative language needed to ren…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis